Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
| Status: | Terminated |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 40 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | March 2012 |
| End Date: | January 2014 |
The study is designed to evaluate the use of ETT ECG indices as biomarkers in the assessment
of atherosclerotic coronary vascular disease (ASCVD).
of atherosclerotic coronary vascular disease (ASCVD).
Inclusion Criteria:
- History of stable coronary artery disease
Exclusion Criteria:
- • Inability or unwillingness to participate in multiple exercise treadmill tests
and/or any other requirements of this study as assessed by the Investigator.
- History of chronic atrial fibrillation.
Other protocol-defined inclusion/exclusion criteria may apply.
We found this trial at
2
sites
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials